Abstract
Objectives Improving help-seeking behaviour is a key component of down-staging breast cancer and improving survival, but the specific challenges faced by low-income women in an Asian setting remain poorly characterized. Here, we determined the extent of help-seeking delay among Malaysian breast cancer patients and explored sub-groups of women who may face specific barriers.
Methods Time to help-seeking was assessed in 303 women diagnosed with advanced breast cancer between January 2015 and March 2020 at a suburban tertiary hospital in Malaysia. Two-step cluster analysis was conducted to identify subgroups of women who share similar characteristics and barriers. Barriers to help-seeking were identified from nurse interviews and were analyzed using behavioural frameworks.
Results The average time to help-seeking was 65 days (IQR = 250 days), and up to 44.5% of women delayed by at least 3 months. Three equal-sized clusters emerged with good separation by time to help-seeking (p<0.001). The most reported barrier across clusters was poor knowledge (36.3%), regardless of help-seeking behaviour (p=0.931). Unexpectedly, women with no delay (9 days average) and great delay (259 days average) were more similar to each other than to women with mild delays (58 days average). In contrast, women who experienced great delay reported poor motivation (p=0.066) and social opportunities (p=0.374) to seek help.
Conclusions Down-staging of breast cancer in Malaysia will require a multi-pronged approach aimed at alleviating culturally specific social and emotional barriers, eliminating misinformation, and instilling motivation to seek help for breast health for the women most vulnerable to help-seeking delays.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by charitable funds received by Cancer Research Malaysia (CRMY) through Sime Darby LPGA, Yayasan Sime Darby, and Yayasan PETRONAS.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for The Patient Navigation Programme was obtained from the Malaysian Medical Research Ethics Committee (NMRR-17-2951-35223), Ministry of Health Malaysia, and conforms to the principles of the Declaration of Helsinki. Permission to use patient data for analysis was sought from the hospital under the governance of the Malaysian Ministry of Health.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
